(19)
(11) EP 0 835 104 A1

(12)

(43) Date of publication:
15.04.1998 Bulletin 1998/16

(21) Application number: 96923579.0

(22) Date of filing: 28.06.1996
(51) International Patent Classification (IPC): 
C07D 207/ 50( . )
A61K 31/ 165( . )
A61K 31/ 192( . )
A61K 31/ 40( . )
A61K 31/ 437( . )
A61K 31/ 546( . )
A61P 7/ 06( . )
C07D 495/ 22( . )
C07K 14/ 47( . )
A61K 31/ 12( . )
A61K 31/ 166( . )
A61K 31/ 195( . )
A61K 31/ 435( . )
A61K 31/ 50( . )
A61K 45/ 00( . )
C07D 495/ 14( . )
C07D 501/ 36( . )
(86) International application number:
PCT/US1996/011158
(87) International publication number:
WO 1997/002024 (23.01.1997 Gazette 1997/05)
(84) Designated Contracting States:
BE CH DE ES FR GB IT LI NL

(30) Priority: 30.06.1995 US 19950497357
08.02.1996 US 19960598715

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
King of Prussia, PA 19406-0939 (US)

(72) Inventor:
  • DUNNINGTON, Damien, John
    Lafayette Hill, PA 19444 (US)

(74) Representative: Waters, David Martin, Dr., et al 
Smithkline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) USE OF STAT 5 SH2 DOMAIN SPECIFIC COMPOUNDS TO ENHANCE ERYTHROPOIESIS